Suchergebnisse - "Young, Barnaby E"

PubPharm (78)

11

Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters

enthalten in: Journal of Medical Virology | 2023

von Rouers, A. | Wong, N. | Goh, Y. | +31

12

Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant : Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Poh, X. | Tan, C. | Lee, I. | +23

13

Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5

enthalten in: The Lancet. Microbe | 2022

von Tan, C. | Lim, B. | Young, B. | +8

14

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

enthalten in: bioRxiv.org | 2022

von Chan, C. | Seah, S. | Chye, D. | +29

15

A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines

enthalten in: Cell reports. Medicine | 2022

von Lim, J. | Hang, S. | Hariharaputran, S. | +10

16

SARS-CoV-2 Omicron variant emerged under immune selection

enthalten in: Nature microbiology | 2022

von Tan, C. | Chia, W. | Zhu, F. | +20

17

DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults

enthalten in: NPJ vaccines | 2022

von Sadarangani, S. | Young, B. | Lian, W. | +6

18

Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants

enthalten in: Microbiology spectrum | 2022

von Cheng, H. | Lim, S. | Jia, H. | +13

19

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19 : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Ginde, A. | Paredes, R. | +98

CommentIn: Lancet Respir Med. 2022 Oct;10(10):928-930. - PMID 35817073

20

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

enthalten in: American journal of respiratory and critical care medicine | 2022

von Douin, D. | Siegel, L. | Grandits, G. | +27

CommentIn: Am J Respir Crit Care Med. 2022 Sep 15;206(6):659-660. - PMID 35608532